Anti-CD20 therapies, a type of MS treatment, changes levels and profiles of several immune cells in people with MS, a study ...

In the past dozen years, doctors have tried no fewer than 50 promising drugs and other treatments for multiple sclerosis. In no case has the promise been fulfilled. “MS” remains an inexorable ...

Multiple sclerosis (MS) affects roughly 2.5 million people worldwide and is a neurological disease affecting the brain and spinal cord. More specifically, MS is when the immune system attacks the body ...

EBV infection has long been associated with multiple sclerosis, but how the infection might contribute to multiple sclerosis has not been clear. More than 95% of people have been infected with this ...

After a single dose of equecabtagene autoleucel, three people with progressive MS saw benefits, including improved walking ...

An illustration of damaged nerve cells caused by multiple sclerosis. In this image, the nerve cells are blue, and immune system cells are orange. ... Let’s start with a little immunology 101.

According to a 2022 study, the estimated total economic burden of multiple sclerosis in the U.S. was $85.4 billion in 2019, with a direct medical cost of $63.3 billion; indirect and nonmedical ...

Reference: Li R, Lei Y, Rezk A, et al. Oxidative phosphorylation regulates B cell effector cytokines and promotes inflammation in multiple sclerosis. Sci Immunol. 2024;9(95):eadk0865. doi: ...

Impact of Multiple Sclerosis. ... $20, the research is being federally funded with the help of the National Institutes of Health’s Center for Human Immunology, Inflammation, ...

No matter how mild or severe your symptoms are, multiple sclerosis self-care options can make a difference. Create a ‘feel good’ toolkit MS is a persistent condition, even if some symptoms ...